Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body's ability to produce its own insulin. A new technology developed by scientists at the ...

Merck's blockbuster immunotherapy Keytruda, which generates nearly half of its total revenue, is scheduled to lose U.S. patent protection in 2028, opening the door to lower-cost generic competition.

Co-infection of influenza virus and SARS-CoV-2 can lead to more severe disease than infection of either alone.

The suicidal impulse so often begins with left-leaning researchers in elite universities (i.e., the tenured in search of a novel, grant-getting theory). They begin insisting that a new existential ...

BioNTech SE is transitioning from a COVID-19 vaccine story to a late-stage oncology platform with a robust $17B cash position. Click to read why BNTX is a Buy.

A protein’s life is anything but simple. Discover how transcription, translation, folding, modification, and degradation work together to preserve proteome integrity.

The policy-focused stop, to be held at Workscapes on E. Clark Street, comes a day after Donalds announced another ...

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.

The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...

During the COVID-19 pandemic, President Donald Trump then described mRNA technology as a "modern-day miracle." HealthDay News — In a major blow to vaccine development, the US Food and Drug ...

Since being sworn in as Health and Human Services (HHS) secretary, Robert F. Kennedy Jr has repeatedly tried to undermine public trust in vaccines. His agency recently took steps to slow down the ...

Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...